Relay Therapeutics (RLAY)
US Market

Relay Therapeutics (RLAY) Financial Statements


Relay Therapeutics Financial Overview

Relay Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.8; its P/E ratio is -3.98; Relay Therapeutics is scheduled to report earnings on August 10, 2023, and the estimated EPS forecast is $-0.80. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 226.00K$ 253.00K$ 344.00K$ 365.00K$ 419.00K
Gross Profit$ 226.00K----
EBIT$ -101.18M$ -83.39M$ -82.63M$ -77.61M$ -67.32M
EBITDA$ -102.00M$ -82.23M$ -81.60M$ -76.66M$ -66.34M
Net Income Common Stockholders$ -94.24M$ -67.50M$ -84.17M$ -76.79M$ -62.05M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 161.28M$ 998.92M$ 1.05B$ 837.99M$ 898.18M
Total Assets$ 1.04B$ 1.10B$ 1.17B$ 889.42M$ 949.88M
Total Debt$ 56.75M$ 57.74M$ 60.28M$ 22.02M$ 22.48M
Net Debt$ -104.53M$ -941.17M$ -993.51M$ -815.97M$ -875.70M
Total Liabilities$ 154.15M$ 149.55M$ 168.95M$ 109.78M$ 107.91M
Stockholders Equity$ 883.41M$ 950.22M$ 999.77M$ 779.64M$ 841.97M
Cash Flow-
Free Cash Flow$ -69.05M$ -59.40M$ -68.24M$ -58.95M$ -51.97M
Operating Cash Flow$ -67.13M$ -57.08M$ -66.14M$ -57.09M$ -49.17M
Investing Cash Flow$ 75.31M$ -146.94M$ 27.19M$ 43.39M$ -112.38M
Financing Cash Flow$ 1.30M$ 1.17M$ 285.87M$ 2.00M$ 883.00K
Currency in USD

Relay Therapeutics Earnings and Revenue History

Relay Therapeutics Debt to Assets

Relay Therapeutics Cash Flow

Relay Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis